The first demonstration of BMPR2 gene therapy was conducted successfully in 2007 in the chronic hypoxia rat model of pulmonary hypertension (PH), yet the clinical translation of a gene therapy approach is challenging [24]. The gene discussed is BMPR2; the disease is pulmonary hypertension.